Improving medical care and prevention in adults with congenital heart disease-reflections on a global problem-part I: development of congenital cardiology, epidemiology, clinical aspects, heart failure, cardiac arrhythmia.
暂无分享,去创建一个
S. Achenbach | T. Meinertz | M. Weyand | D. Celermajer | R. Oberhoffer | P. Ewert | L. Pieper | D. Pittrow | U. Bauer | C. Schlensak | D. Lossnitzer | N. Nagdyman | E. Oechslin | K. Niwa | H. Kaemmerer | J. Aboulhosn | Y. von Kodolitsch | H. Kallfelz | R. Neidenbach | Oeztekin Oto | J. Schelling | L. Sanftenberg | F. de Haan | O. Oto
[1] Stephanie Fuller,et al. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2019, Circulation.
[2] R. Oberhoffer,et al. Non-cardiac comorbidities in adults with inherited and congenital heart disease: report from a single center experience of more than 800 consecutive patients. , 2018, Cardiovascular diagnosis and therapy.
[3] D. Celermajer,et al. Heart failure admissions and poor subsequent outcomes in adults with congenital heart disease , 2018, European journal of heart failure.
[4] J. Mulder,et al. Current state of risk stratification for sudden cardiac death in adults with congenital heart disease , 2018, Anatolian journal of cardiology.
[5] I. V. Van Gelder,et al. Cardiac resynchronization therapy in adults with congenital heart disease , 2018, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[6] G. Diller,et al. Systemic Right Ventricle in Adults With Congenital Heart Disease: Anatomic and Phenotypic Spectrum and Current Approach to Management , 2018, Circulation.
[7] D. Negura,et al. Heart failure in grown-up congenital heart disease. , 2018, Minerva cardioangiologica.
[8] D. Morales,et al. Overview of adult congenital heart transplants. , 2018, Annals of cardiothoracic surgery.
[9] D. Celermajer,et al. Incidence and clinical characteristics of sudden cardiac death in adult congenital heart disease. , 2017, International journal of cardiology.
[10] Joseph D. Kay,et al. Diagnosis and Management of Noncardiac Complications in Adults With Congenital Heart Disease: A Scientific Statement From the American Heart Association. , 2017, Circulation.
[11] S. Kutty,et al. An Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of hospitalization, functional status, and mortality after mechanical circulatory support in adults with congenital heart disease. , 2017, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[12] O. Ziff,et al. Digoxin: The good and the bad. , 2016, Trends in cardiovascular medicine.
[13] J. Triedman,et al. Trends in Congenital Heart Disease: The Next Decade , 2016, Circulation.
[14] O. Tutarel,et al. Cause of death in adults with congenital heart disease - An analysis of the German National Register for Congenital Heart Defects. , 2016, International journal of cardiology.
[15] A. Niesert,et al. Usefulness of Direct Oral Anticoagulants in Adult Congenital Heart Disease. , 2016, The American journal of cardiology.
[16] K. Dimopoulos,et al. Common long-term complications of adult congenital heart disease: avoid falling in a H.E.A.P. , 2016, Expert review of cardiovascular therapy.
[17] R. Ohye,et al. Berlin heart ventricular assist device as a long‐term bridge to transplantation in a Fontan patient with failing single ventricle , 2015, Pediatric transplantation.
[18] S. Hohnloser,et al. Digoxin-associated mortality: a systematic review and meta-analysis of the literature. , 2015, European heart journal.
[19] P. Robinson,et al. The Application of Clinical Genetics Dovepress Perspectives on the Revised Ghent Criteria for the Diagnosis of Marfan Syndrome , 2022 .
[20] K. Liestøl,et al. Achievements in congenital heart defect surgery: a prospective, 40-year study of 7038 patients. , 2015, Circulation.
[21] G. MacGowan,et al. Durable ventricular assist device support for failing systemic morphologic right ventricle: early results. , 2014, The Annals of thoracic surgery.
[22] Nandini Dendukuri,et al. Lifetime Prevalence of Congenital Heart Disease in the General Population From 2000 to 2010 , 2014, Circulation.
[23] M. Abrahamowicz,et al. Specialized Adult Congenital Heart Disease Care: The Impact of Policy on Mortality , 2014, Circulation.
[24] D. Driscoll,et al. Cardiac and multiorgan transplantation for end-stage congenital heart disease. , 2014, Mayo Clinic proceedings.
[25] D. Grobbee,et al. Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. , 2013, International journal of cardiology.
[26] U. Bauer,et al. [Adults with congenital heart disease: treatment and medical problems]. , 2013, Herz.
[27] J. Hoffman. The global burden of congenital heart disease , 2013, Cardiovascular journal of Africa.
[28] J. Moriarty,et al. Efficacy of endothelin blockade in adults with Fontan physiology. , 2013, Congenital Heart Disease.
[29] S. Qureshi,et al. Association for European Paediatric and Congenital Cardiology , 2012, Cardiology in the Young.
[30] J. Roos‐Hesselink,et al. Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. , 2011, Journal of the American College of Cardiology.
[31] R. Davies,et al. Listing and Transplanting Adults With Congenital Heart Disease , 2011, Circulation.
[32] M. Abrahamowicz,et al. Changing mortality in congenital heart disease. , 2010, Journal of the American College of Cardiology.
[33] D. Grobbee,et al. Mortality in adult congenital heart disease. , 2010, European heart journal.
[34] J. Hess,et al. [Congenital heart disease. Transition from adolescence to adulthood]. , 2009, Der Internist.
[35] B. Diggs,et al. National Practice Patterns for Management of Adult Congenital Heart Disease: Operation By Pediatric Heart Surgeons Decreases In-Hospital Death , 2008, Circulation.
[36] Geoffrey I. Webb,et al. Effect of angiotensin receptor blockade on systemic right ventricular function and size: a small, randomized, placebo-controlled study. , 2008, International journal of cardiology.
[37] H. Sairanen,et al. Causes of late deaths after pediatric cardiac surgery: a population-based study. , 2007, Journal of the American College of Cardiology.
[38] J. Child,et al. The adult with a Fontan operation , 2007, Current cardiology reports.
[39] A. Ducharme,et al. Angiotensin Receptor Blockade and Exercise Capacity in Adults With Systemic Right Ventricles: A Multicenter, Randomized, Placebo-Controlled Clinical Trial , 2005, Circulation.
[40] C. Warnes,et al. The adult with congenital heart disease: born to be bad? , 2005, Journal of the American College of Cardiology.
[41] J. Hess,et al. Surgical treatment of patent ductus arteriosus: a new historical perspective. , 2004, The American journal of cardiology.
[42] R. Quaife,et al. Improved systemic ventricular function after carvedilol administration in a patient with congenitally corrected transposition of the great arteries. , 2003, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[43] J. W. Moore,et al. Afterload Reduction Therapy in Patients Following Intraatrial Baffle Operation for Transposition of the Great Arteries , 2002, Pediatric Cardiology.
[44] S. Siu,et al. Heart Failure and Ventricular Dysfunction in Patients With Single or Systemic Right Ventricles , 2002, Circulation.
[45] E. Foster,et al. Effects of losartan in patients with a systemically functioning morphologic right ventricle after atrial repair of transposition of the great arteries. , 2001, The American journal of cardiology.
[46] C A Warnes,et al. Challenges posed by adults with repaired congenital heart disease. , 2001, Circulation.
[47] Geoffrey I. Webb,et al. Angiotensin-converting enzyme inhibitors in adults after the Mustard procedure. , 2001, The American journal of cardiology.
[48] S. Siu,et al. Mode of death in adults with congenital heart disease. , 2000, The American journal of cardiology.
[49] V. McKusick,et al. Life expectancy and causes of death in the Marfan syndrome. , 1972, The New England journal of medicine.
[50] P. Eghtesady,et al. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). , 2018, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.
[51] W. Budts,et al. Management of acute heart failure in adult patients with congenital heart disease , 2017, Heart Failure Reviews.
[52] Volkmar Falk,et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure. , 2016, Revista espanola de cardiologia.
[53] Gianfranco Ferrari,et al. Hemodynamic Effects of Ventricular Assist Device Implantation on Norwood, Glenn, and Fontan Circulation: A Simulation Study. , 2016, Artificial organs.
[54] J. Hess,et al. [Adult patients with congenital heart abnormalities: present and future]. , 2005, Deutsche medizinische Wochenschrift.
[55] J. Stark. Do we really correct congenital heart defects? , 1989, Journal of Thoracic and Cardiovascular Surgery.